Letter highlights emotional distress and aging effects from rapid weight loss in patients using semaglutide, indicating a need for greater awareness.
UNSTRUCTURED The increasing use of Semaglutide, a GLP 1 agonist, for diabetes and obesity is resulting in a noticeable side effect known as "Ozempic face ". This is characterised by sudden fat loss on the face resulting in an aged appearance. This is causing loss of self confidence and emotional distress among the patients. The unchecked use of this medication has resulted in unintended consequences. This letter highlights the need for awareness among the public and doctors about the potential side effects of these medications.
No takes yet. Share an insight, caveat, or question.
Kashif Kashif Zarnaab (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: